Rivastigmine
| Use attributes for filter ! | |
| Molar mass | 250. 337 g/mol |
|---|---|
| CAS ID | 123441-03-2 |
| Formula | C14H22N2O2 |
| Trade name | Exelon, others |
| Bioavailability | 60 to 72% |
| Elimination half-life | 1. 5 hours |
| Metabolism | Liver, via pseudocholinesterase |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2922154 |
About Rivastigmine
Rivastigmine is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.